Piyasa kapalı· · INR · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
MIAMI, September 29, 2026--Indigo, a vertically integrated, AI-driven medical professional liability platform, today announced that it has surpassed $20 million in premiums, doubling the company’s premium volume since announcing its $50 million Series B financing in January. The milestone reflects growing adoption among larger physician groups, continued expansion of Indigo’s curated broker network, and strong underwriting performance as the medical malpractice insurance market faces increasing
Oil just slipped back below the psychological $100 mark for Brent and $90 for WTI, easing some of the pressure that has stalked fuel intensive transport and logistics stocks in recent months. When a key input suddenly gets cheaper, cost structures can look very different, and that can shift how investors think about everything from airlines to freight operators. This article walks through 3 stocks from our Fuel intensive Transportation and Logistics Stocks screener that are directly exposed...
– New data from the Phase 3 INDIGO open-label extension will include the longer-term flare protection and safety data of obexelimab in IgG4-RD – – Additional analyses will assess glucocorticoid-associated toxicity and vaccine responses – WALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company advancing therapies for patients living with autoimmune and inflammatory diseases, today announc
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.